Thus, this study aimed to investigate the clinicopathological characteristics of YY1 expression and its association with survival outcomes independently and in connection with CP2c expression using formalin-fixed paraffin-embedded (FFPE) tissue blocks from patients with primary breast cancer. The gene discussed is YY1; the disease is breast carcinoma.